Studies Highlight Effectiveness of SBRT for Lung Cancer

Numerous studies continue to increase clinical research findings detailing the effectiveness of stereotactic body radiation therapy (SBRT) for lung cancer. A few of these findings are listed below:

• The German Society of Radiation Oncology collected data from nearly 600 non-small cell lung cancer patients who underwent SBRT. Thanks in large part to the radiotherapy dosage; they found consistently low rates of the spread of tumors. Find more details on the study from the International Association for the Study of Lung Cancer.

• In a study completed by Virginia Hospital Center and Georgetown University Hospital, researchers found that combining SBRT with other forms of treatment for non-small cell lung cancer can increase survival outcomes. Read more here.

• A recent study by members of the Japan Clinical Oncology Group (JCOG) found that SBRT for early stage medically inoperable non-small cell lung cancer doubled overall survival rates as compared to conventional radiation treatment. The study also examined the safety and efficacy of SBRT for 100 lung cancer patients treated over four years. Results show that patients exhibited minimal toxicity and improved survival rates. Read more at the Radiological Society of North America.

At Oklahoma CyberKnife, lung cancer patients are treated with SBRT using CyberKnife^® technology. View our SlideShare profile for a presentation on the treatment process for lung tumors.

This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.